MB
Microbix Biosystems Inc.
MBXBF · OTC
$0.22 +0.00% (+$0.00)
1M +1.54%
Market Cap $42.2M
P/E Ratio -
Div. Yield -
ROE 16.97%
Bulios Fair Price
$0.2
7.8% downside
Current Price
$0.22
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MBXBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
79 /100
Cheap P/S 2.74x
P/B 1.74x
P/E N/A
Growth
22 /100
Declining Rev. growth 0.82%
Book val. growth 3.72%
EPS growth N/A
Profitability
18 /100
Weak Gross margin 45.88%
Net margin 28.60%
Op. margin 28.53%
Quality
6 /100
Poor ROIC 13.92%
ROE 16.97%
ROA 12.94%
Debt
69 /100
Low Debt/Equity 0.28x
Current ratio 6.89x
Int. coverage -3.82x
Stability
24 /100
Unstable Beta 0.57x
Rev. volatility 43.14%
EPS volatility 5,061.24%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MBXBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cameron L. Groome
Employees
100
Headquarters
Mississauga
Upcoming events
17 DEC
Earnings
Upcoming earnings report